2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 14, 2025.

via HealthDay

THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D), according to a study published online Aug. 11 in JAMA Network Open.

Michael Fang, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues characterized trends and disparities in glycemic control and use of diabetes technology among U.S. youths and adults with T1D in a serial, cross-sectional analysis using the Optum Labs Data Warehouse.

A total of 186,590 participants with T1D were identified: 26,853 youths (mean age, 12 years) and 159,737 adults (mean age, 45 years). The researchers found an increase in the prevalence of glycemic control (mean hemoglobin A1c <7 percent) from the 2009-2011 to 2021-2023 study periods from 7 to 19 percent in youths and from 21 to 28 percent in adults. During the same period, for youths and adults, there were substantial increases in the percentage of patients using continuous glucose monitoring (4 to 82 percent for youths and 5 to 57 percent for adults); insulin pumps (16 to 50 percent for youths and 11 to 29 percent for adults); and both devices concurrently (1 to 47 percent for youths and 1 to 22 percent for adults). In Hispanic, non-Hispanic Black, and Medicaid-insured youths and adults, the prevalence of glycemic control and use of diabetes technology were lowest; over time, differences persisted or increased.

“Improving glucose control in patients with type 1 diabetes has been challenging, so these big increases are exciting for the field,” Fang said in a statement. “These improvements have likely been driven by the widespread adoption of new monitoring and delivery technologies.”

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-15 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords